Ss innovations to submit de novo application to the fda for the ssi mantra 3 surgical robotic system for multiple indications

All clinical data validated by leading third-party cro for safety, feasibility and efficacy fort lauderdale, fla., may 08, 2025 – prism mediawire – ss innovations international, inc.

SSII Ratings Summary

SSII Quant Ranking